Non-Selective Beta-Blockers Decrease Infection, Acute Kidney Injury Episodes, and Ameliorate Sarcopenic Changes in Patients with Cirrhosis: A Propensity-Score Matching Tertiary-Center Cohort Study
Background: Cirrhotic complications resulting from portal hypertension can be considerably reduced by non-selective beta-blockers (NSBBs); however, scarce studies have investigated therapeutic agents for other complications. We aimed to investigate the effects of NSBBs on common cirrhotic complicati...
Main Authors: | Tzu-Hao Li, Chih-Wei Liu, Chia-Chang Huang, Yu-Lien Tsai, Shiang-Fen Huang, Ying-Ying Yang, Chang-Youh Tsai, Ming-Chih Hou, Han-Chieh Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/11/2244 |
Similar Items
-
Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact
by: Hiroki Nishikawa, et al.
Published: (2021-02-01) -
Beta-blockers in Prevention of Development of Varices and Variceal Bleeding in Cirrhosis: Current Management, Controversies, and Future Directions
by: Dhiraj Tripathi
Published: (2017-06-01) -
Sarcopenic obesity in liver disease: Handling both sides of the penny
by: Yangyang Hui, et al.
Published: (2022-06-01) -
Pathophysiological-Based Nutritional Interventions in Cirrhotic Patients with Sarcopenic Obesity: A State-of-the-Art Narrative Review
by: Ernestina Santangeli, et al.
Published: (2024-01-01) -
Association between Dietary Habits and Sarcopenia in Patients with Liver Cirrhosis
by: Mirabela-Madalina Topan, et al.
Published: (2023-07-01)